This study showed the utility of MYO1E DNA methylation detection in predicting NSCLC patients’ survival and suggested that changes in MYO1E methylation and expression in LUAD have an important role in the pathogenesis of this disease. Here, MYO1E is linked to non-small cell lung carcinoma.